Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond

Chim, CS; Kumar, SK; Orlowski, RZ; Cook, G; Richardson, PG; Gertz, MA; Giralt, S; Mateos, MV; Leleu, X; Anderson, KC

Chim, CS (reprint author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.

LEUKEMIA, 2018; 32 (2): 252

Abstract

Despite enormous advances, management of multiple myeloma (MM) remains challenging. Multiple factors impact the decision to treat or which regimen to ......

Full Text Link